共 78 条
[1]
Belani CP(2003)Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation J Clin Oncol 21 2933-2939
[2]
Barstis J(1999)Multicenter phase II study of capecitabine in paclitaxel refractory metastatic breast cancer J Clin Oncol 17 485-493
[3]
Perry MC(2006)Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial Lung Cancer 52 155-163
[4]
Blum JL(2002)First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin Ann Oncol 13 566-575
[5]
Jones SE(2004)XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer J Clin Oncol 22 2084-2091
[6]
Buzdar AU(2008)Randomized Phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer J Clin Oncol 26 2006-2012
[7]
Brodowicz T(1990)Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate J Natl Cancer Inst 82 1046-1050
[8]
Krzakowski M(2006)The molecular epidemiology study of environment exposure and metabolic enzyme gene polymorphism in colorectal cancer Chin J Epidemiol 27 905-908
[9]
Zwitter M(2008)Capecitabine, alone and in combination, in the management of patients with colorectal cancer: a review of the evidence Drugs 68 949-961
[10]
Cassidy J(2000)Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2938-2947